EP0932406A4 - Methods of treating or preventing interstitial cystitis - Google Patents
Methods of treating or preventing interstitial cystitisInfo
- Publication number
- EP0932406A4 EP0932406A4 EP97908927A EP97908927A EP0932406A4 EP 0932406 A4 EP0932406 A4 EP 0932406A4 EP 97908927 A EP97908927 A EP 97908927A EP 97908927 A EP97908927 A EP 97908927A EP 0932406 A4 EP0932406 A4 EP 0932406A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treating
- methods
- interstitial cystitis
- preventing interstitial
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000005615 Interstitial Cystitis Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1313096P | 1996-03-11 | 1996-03-11 | |
US613130P | 1996-03-11 | ||
PCT/US1997/003555 WO1997033583A1 (en) | 1996-03-11 | 1997-03-07 | Methods of treating or preventing interstitial cystitis |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0932406A1 EP0932406A1 (en) | 1999-08-04 |
EP0932406A4 true EP0932406A4 (en) | 2000-07-05 |
Family
ID=21758466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP97908927A Withdrawn EP0932406A4 (en) | 1996-03-11 | 1997-03-07 | Methods of treating or preventing interstitial cystitis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0932406A4 (en) |
JP (1) | JP2000506527A (en) |
AU (1) | AU2071497A (en) |
CA (1) | CA2247822A1 (en) |
WO (1) | WO1997033583A1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9508375A (en) * | 1994-07-12 | 1997-10-28 | Lilly Co Eli | Heterocyclic tachykinin receptor antagonist |
-
1997
- 1997-03-07 JP JP9532693A patent/JP2000506527A/en active Pending
- 1997-03-07 EP EP97908927A patent/EP0932406A4/en not_active Withdrawn
- 1997-03-07 CA CA002247822A patent/CA2247822A1/en not_active Abandoned
- 1997-03-07 AU AU20714/97A patent/AU2071497A/en not_active Abandoned
- 1997-03-07 WO PCT/US1997/003555 patent/WO1997033583A1/en not_active Application Discontinuation
Non-Patent Citations (2)
Title |
---|
No further relevant documents disclosed * |
See also references of WO9733583A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2000506527A (en) | 2000-05-30 |
EP0932406A1 (en) | 1999-08-04 |
WO1997033583A1 (en) | 1997-09-18 |
AU2071497A (en) | 1997-10-01 |
CA2247822A1 (en) | 1997-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA965088B (en) | Methods of preventing or treating allergles | |
GB9617780D0 (en) | Method of treatment | |
GB9824436D0 (en) | Methods of treatment | |
IL134718A0 (en) | Treatment of conduct disorder | |
AU2207897A (en) | Methods of treating or preventing interstitial cystitis | |
EP0795035A4 (en) | Treatment of hides | |
EP0711168A4 (en) | Methods of treating apoptosis and associated conditions | |
GB9715295D0 (en) | Novel method of treatment | |
GB9712866D0 (en) | Novel method of treatment | |
HUP9902884A2 (en) | Use of duloxetine for treating or preventing interstitial cystitis | |
GB9707693D0 (en) | Novel method of treatment | |
GB9715298D0 (en) | Novel method of treatment | |
GB9715306D0 (en) | Novel method of treatment | |
EP0938296A4 (en) | Method of treating alopecia | |
ZA971958B (en) | Treatment of cocoa | |
ZA973988B (en) | Method of treatment | |
GB9618341D0 (en) | Method of treatment | |
EP0932406A4 (en) | Methods of treating or preventing interstitial cystitis | |
GB9317943D0 (en) | Treatment of laminitis | |
GB9415902D0 (en) | Method of treatment | |
GB9407335D0 (en) | Method of treatment | |
GB9602404D0 (en) | Methods of treatment | |
GB9414652D0 (en) | Method of treatment | |
GB9600888D0 (en) | Method of treatment | |
GB9317989D0 (en) | Treatment of laminitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980909 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20000524 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 31/445 A, 7C 07D 401/14 B, 7A 61K 31/495 B |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
17Q | First examination report despatched |
Effective date: 20030220 |
|
18D | Application deemed to be withdrawn |
Effective date: 20021001 |